Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 31,265

Document Document Title
WO/2016/195115A1
A supported catalyst for aldehyde coupling reaction, comprising a carrier having supported thereon a catalyst comprising at least one azolium compound selected from the group consisting of a thiazolium salt, an imidazolium salt, a benzim...  
WO/2016/195361A1
The present invention provides: a novel benzylidene dihydroindenone derivative; and a composition for preventing or treating inflammatory bowel disease, containing the same. The benzylidene dihydroindenone derivative maintains the thickn...  
WO/2016/193822A1
A process for preparing (E)-(5,6-dihydro-l,4,2-dioxazin-3-yl)(2- hydroxyphenyl)methanone O-methyl oxime is described which includes: (i) reacting benzofuran-3(2H)-one O-methyl oxime (1) with at least one nitrite selected from n-butyl nit...  
WO/2016/193459A1
The present invention relates to compounds according to Formula I: or a pharmaceutically acceptable salt thereof. The compounds can be used as inhibitors of RORy and are useful for the treatment of RORy mediated diseases such as autoimmu...  
WO/2016/192631A1
The present invention provides an abietane-type diterpene compound having lipid-lowering activity, a method for preparing same, and use of same. Specifically, the compound has the structure shown in formula I. The definitions of the grou...  
WO/2016/193332A1
Ether analogues of galiellalactone, methods of preparing the analogues, and use of the analogues in the treatment of cancer are disclosed.The analogues are of formula (I) or (II):  
WO/2016/195500A1
A purified acid composition comprising 2,5-furandicarboxylic acid is prepared in a process, comprising (i) oxidizing a feedstock containing 5-alkoxymethylfurfural to an oxidation product comprising 2,5-furandicarboxylic acid (FDCA) and 2...  
WO/2016/189876A1
The present invention provides a urea derivative or a pharmacologically acceptable salt thereof that has a formyl peptide receptor like 1 (hereinafter may be abbreviated as FPRL1) agonist effect, a pharmaceutical composition containing t...  
WO/2016/189877A1
The present invention provides a urea compound or a pharmacologically acceptable salt thereof that has a formyl peptide receptor like 1 (hereinafter may be abbreviated as FPRL1) agonist effect, a pharmaceutical composition containing the...  
WO/2016/191682A1
Acid chloride derivatives of 5-(chloromethyl)furan-2-carboxylic acid and furan-2,5-dicarboxylic acid (FDCA) can be produced in high yield by treatment of the precursor aldehydes 5-(chloromethyl)furfural (CMF) and 2,5-diformylfuran (DFF) ...  
WO/2016/190739A1
A fructose-rich solution is prepared from a solid composition comprising fructose and glucose, in a process comprising i) admixing the solid composition comprising fructose and glucose with a selective solvent that consist for at least 8...  
WO/2016/190170A1
A polyimide, which is produced from a tetracarboxylic acid dianhydride represented by formula (1) and having both a cyclic hydrocarbon skeleton and an ester group, has excellent solubility in solvents, excellently low dielectric properti...  
WO/2016/190600A1
The present invention provides a compound represented by chemical formula 1. Further, the present invention provides an organic electric element comprising a first electrode, a second electrode, and an organic matter layer between the fi...  
WO/2016/186276A1
The present invention relates to an organic compound represented by chemical formula 1, an organic optoelectronic element, and a display device.  
WO/2016/186278A1
The present invention relates to a method for preparing 2,5-furandicarboxylic acid (FDCA), the method comprising oxidizing 5-hydroxymethylfurfural (HMF) in a mixture solvent containing an alcohol and an organic acid, in the presence of a...  
WO/2016/186505A1
A carboxylic acid-containing composition, which composition contains an aldehyde, is purified in a process, which process comprises introducing the carboxylic acid-containing composition and an aqueous electrolyte into an electrolytic ce...  
WO/2016/186504A1
An aromatic dicarboxylic acid of chemical formula HOOC-Ar1-COOH is prepared in a process wherein a feedstock comprising at least an aromatic aldehyde compound of chemical formula (1): OHC-Ar1-COOH, wherein Ar1 represents an arylene or he...  
WO/2016/186963A1
The present invention provides a compound having the structure : Formula (I).  
WO/2016/181413A1
The present invention relates to an enantiospecific process for the preparation of (R) and (S) enantiomers of sex pheromones of the long-tailed mealybug with high enantiopurity.  
WO/2016/181413A4
The present invention relates to an enantiospecific process for the preparation of (R) and (S) enantiomers of sex pheromones of the long-tailed mealybug with high enantiopurity.  
WO/2016/178544A2
The present invention relates to a novel compound and, more particularly, to a novel compound which forms a deep HOMO, has a high LUMO enabling easy electron blocking, and has an excellent hole mobility, thereby suppressing a roll-off ph...  
WO/2016/178544A3
The present invention relates to a novel compound and, more particularly, to a novel compound which forms a deep HOMO, has a high LUMO enabling easy electron blocking, and has an excellent hole mobility, thereby suppressing a roll-off ph...  
WO/2016/176082A1
Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, wherein R1, R2, R3, R4, R5, Q1, Q2, Y1, and Y2 are as defined in the disclosure. Also disclosed are compositions containing the compounds of ...  
WO/2016/175533A2
The purpose of the present invention is to provide: a compound having a high light emitting efficiency, a low driving voltage, and an improved lifespan of an element; an organic electronic element using the same; and an electronic device...  
WO/2016/175533A3
The purpose of the present invention is to provide: a compound having a high light emitting efficiency, a low driving voltage, and an improved lifespan of an element; an organic electronic element using the same; and an electronic device...  
WO/2016/173274A1
Aromatic farnesyl compound and application of a pharmaceutical salt thereof as an inhibitor of α-glucosidase, dipeptidyl peptidase-4, aldose reductase, protein tyrosine phosphatase-1B or HMG-CoA reductase, or use thereof in preparing me...  
WO/2016/168938A1
Described herein is an antibiotic compound of formula (I): or a salt or stereoisomer thereof; wherein R1-R3, R5 and R6 are independently selected from H, alkyl group, substituted alkyl group, halogen, OH, NH2, or SH; R4 is H, alkyl group...  
WO/2016/172655A1
Disclosed herein are compounds, salts, solvates of Formula (1), and any formulation thereof. Also disclosed are methods of eliciting hydraulic enhancement and/or increasing yield of a plant by contacting a plant with compounds, salts, so...  
WO/2016/172556A1
In one aspect, methods of HMF production are described herein. A method of HMF production, in some embodiments, comprises providing a saccharide feedstock including glucose and bringing the saccharide feedstock into contact with a solid ...  
WO/2016/171429A3
The present invention relates to any one anthracene derivative selected from [Chemical Formula A-1], [Chemical Formula A-2], [Chemical Formula B-1] and [Chemical Formula B-2], and to an organic light emitting diode including the anthrace...  
WO/2016/169573A1
The present invention relates to potent HCV entry inhibitors (cynaropicrin and grosheimol), in addition to mono-caffoeylquinic acid derivatives which have also anti-HCV activity but less than cynaropicrin and grosheimol.  
WO/2016/171429A2
The present invention relates to any one anthracene derivative selected from [Chemical Formula A-1], [Chemical Formula A-2], [Chemical Formula B-1] and [Chemical Formula B-2], and to an organic light emitting diode including the anthrace...  
WO/2016/168058A1
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions con...  
WO/2016/166421A1
According to an example aspect of the present invention, there is provided a method of producing furan carboxylates from aldaric acids in the presence of a solid heterogeneous catalyst and a solvent with short reaction time. The feedstoc...  
WO/2016/167491A1
The present invention provides a compound represented by chemical formula 1. In addition, the present invention provides an organic electronic element comprising a first electrode, a second electrode, and an organic material layer betwee...  
WO/2016/168675A1
Provided is a method of producing activated carbon from a resin composite made up of furanic polymer. The method includes producing a resin composite from feedstock (e.g., in the presence of an acid and a salt), combining the resin compo...  
WO/2016/168233A1
An integrated process is described for producing 2,5-furandicarboxylic acid and/or a derivative thereof from a six carbon sugar-containing feed, comprising: a) dehydrating a feed comprising a six-carbon sugar unit, in the presence of a b...  
WO/2016/164828A1
PLGA-based polymers include pendant nucleophiles protected with photocleavable protecting groups. Upon deprotection, the polymers degrade rapidly via intramolecular cyclization into small molecules. The polymer may be formulated as a nan...  
WO/2016/163276A1
[Problem] To provide an organic electroluminescent element which has low driving voltage, high luminous efficiency and a long service life by combining various materials for organic electroluminescent elements having excellent injection/...  
WO/2016/162397A1
The present invention provides a process for the production of THF and 1,4-BDO from furan in the presence of a catalytic composition, wherein the catalytic composition contains at least one metal selected from the group consisting of Fe,...  
WO/2016/162646A1
The present invention relates to a method for preparing a precursor of a single dairy-lactone isomer, to a single dairy-lactone isomer, and to the organoleptic uses thereof.  
WO/2016/161279A1
There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, suc...  
WO/2016/158788A1
The present invention relates to: a fused heterocyclic compound that has enteropeptidase inhibitory activity; and use of the compound as a pharmaceutical product for treatment or prophylaxis of obesity, diabetes and the like. Specificall...  
WO/2016/159021A1
[Problem] To provide a novel compound. [Solution] A compound represented by formula (I) or formula (II), a salt thereof, or a solvate thereof. R1 represents a hydrogen atom or a halogen atom; each of R2-R4 represents a hydrogen atom, a h...  
WO/2016/158706A1
The purpose of the present invention is to provide an industrially advantageous method for producing a furan compound, by which a furan compound is able to be efficiently obtained from a furfural compound with high selectivity. The prese...  
WO/2016/157052A1
The present invention provides compounds represented by formula (1A), or pharmaceutically acceptable salts. Compounds represented by formula (1A), or pharmaceutically acceptable salts thereof, wherein A1 and A2 are identical or different...  
WO/2016/153937A1
A method for synthesizing furan-2, 5-dicarboxylate (FDCA2-) is provided. Furan-2-carboxylic acid is provided. A CO3 2- salt is provided to form a mixture, which converts the furan-2-carboxylic acid to furan-2-carboxylate. CO2 gas is prov...  
WO/2016/151989A1
The present invention can provide novel C-glycoside derivatives which are biologically important under high stereoselective, mild, atom economical condition.  
WO/2016/154599A1
Catalysts useful for the selective hydrogenation of carbonyl groups, including for the reduction of aldehydes to alcohols, are described. The catalysts incorporate palladium and rhenium on an alumina support. Methods of making the cataly...  
WO/2016/153432A1
The present invention relates to substituted phenyl cinnamyl ketones of Formula (I) for use in therapy: wherein R1 to R11 are defined as described in the specification, or a pharmaceutically acceptable salt, tautomer(s), solvate or polym...  

Matches 201 - 250 out of 31,265